Chemoinformaics analysis of 3-Oxo-alpha-ionone
| Molecular Weight | 206.285 | nRot | 2 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 33 |
| Exact Molecular Weight | 206.131 | nRing | 1 |
| Solubility: LogS | -3.222 | nHRing | 0 |
| Solubility: LogP | 2.682 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 35.3163 |
| nHD | 0 | BPOL | 19.7937 |
| QED | 0.177 |
| Synth | 5.459 |
| Natural Product Likeliness | 3.058 |
| NR-PPAR-gamma | 0.467 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.03 |
| Pgp-sub | 0.004 |
| HIA | 0.814 |
| CACO-2 | -5.189 |
| MDCK | 0.0000421 |
| BBB | 0.072 |
| PPB | 0.902707 |
| VDSS | 0.771 |
| FU | 0.0929979 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.2 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.745 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.139 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.133 |
| CYP3a4-inh | 0.117 |
| CYP3a4-sub | 0.096 |
| CL | 1.92 |
| T12 | 0.042 |
| hERG | 0.004 |
| Ames | 0.109 |
| ROA | 0.162 |
| SkinSen | 0.003 |
| Carcinogencity | 0.047 |
| EI | 0.004 |
| Respiratory | 0.205 |
| NR-Aromatase | 0.838 |
| Antiviral | Yes |
| Prediction | 0.602075 |